科罗拉多州每年限制安布雷尔价格为7500美元,用于州卫生计划,从2025年10月1日开始. Colorado caps Enbrel's price at $7,500 annually for state health programs, starting Oct. 1, 2025.

科罗拉多州对Enbrel实行了价格上限,Enbrel是一种治疗关节炎的药物,它成为第一个规定特定生物药物成本上限的国家。 Colorado has implemented a price ceiling on Enbrel, a medication used to treat arthritis, making it the first state to cap the cost of a specific biologic drug. 这一举措旨在提高患者的可负担性并减轻财政负担,上限定为每年7 500美元。 The move aims to improve affordability for patients and reduce financial burden, with the cap set at $7,500 per year. 这项法律自2025年10月1日起生效,适用于国家资助的保健方案,并可能影响其他各州的类似行动。 The law, effective October 1, 2025, applies to state-funded health programs and could influence similar actions in other states.